LINC01173: A Potential Drug Target and Biomarker (G106144537)
LINC01173: A Potential Drug Target and Biomarker
Introduction
LINC01173 is a non-coding RNA (ncRNA) molecule located within the last exon of the human gene 1173. It has been identified as a potential drug target and biomarker due to its unique structure, expression pattern, and function in various cellular processes. In this article, we will provide an overview of LINC01173, its potential drug target properties, and its potential as a biomarker for various diseases.
Structure and Expression
LINC01173 is a 24.8 kilobase (kb) RNA molecule with a unique 5' end that contains a splicing intron and a 3' end that contains a poly(A) tail. It has a calculated molecular weight of 13.8 kDa and a base pairing pattern of G/C-rich. LINC01173 is expressed in various cell types, including brain, heart, and cancer cells. Its expression level varies depending on the cell type and the stage of development.
Function
LINC01173 is involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been shown to play a role in cell proliferation and has been associated with the development of various diseases, including cancer.
Potential Drug Target
LINC01173 has been identified as a potential drug target due to its unique structure and function. It has a small size and a G/C-rich composition, which makes it a good candidate for small molecule inhibitors. Additionally, its expression level varies depending on the cell type, which could make it an effective target for personalized medicine.
LINC01173 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been associated with the development of various diseases, including cancer, and has been shown to have dysregulated expression in cancer cells.
Potential Biomarkers
LINC01173 has the potential to serve as a biomarker for various diseases due to its unique expression patterns and involvement in cellular processes. Its expression level varies depending on the disease stage and has been associated with the development of various diseases, including cancer.
Conclusion
In conclusion, LINC01173 is a non-coding RNA molecule with unique structure and function that has the potential to serve as a drug target and biomarker for various diseases. Its small size and G/C-rich composition make it a good candidate for small molecule inhibitors, and its expression level varies depending on the disease stage, which could make it an effective target for personalized medicine. Further research is needed to fully understand its potential as a drug target and biomarker.
Protein Name: Long Intergenic Non-protein Coding RNA 1173
More Common Targets
LINC01176 | LINC01181 | LINC01186 | LINC01187 | LINC01191 | LINC01192 | LINC01193 | LINC01194 | LINC01198 | LINC01206 | LINC01208 | LINC01210 | LINC01214 | LINC01218 | LINC01220 | LINC01221 | LINC01222 | LINC01224 | LINC01226 | LINC01227 | LINC01230 | LINC01232 | LINC01233 | LINC01234 | LINC01235 | LINC01237 | LINC01238 | LINC01239 | LINC01241 | LINC01243 | LINC01248 | LINC01249 | LINC01252 | LINC01254 | LINC01255 | LINC01257 | LINC01258 | LINC01260 | LINC01262 | LINC01266 | LINC01267 | LINC01269 | LINC01270 | LINC01271 | LINC01276 | LINC01277 | LINC01278 | LINC01280 | LINC01281 | LINC01287 | LINC01288 | LINC01289 | LINC01291 | LINC01293 | LINC01299 | LINC01300 | LINC01303 | LINC01307 | LINC01310 | LINC01311 | LINC01312 | LINC01315 | LINC01317 | LINC01320 | LINC01322 | LINC01331 | LINC01337 | LINC01338 | LINC01339 | LINC01341 | LINC01342 | LINC01343 | LINC01346 | LINC01347 | LINC01348 | LINC01352 | LINC01354 | LINC01355 | LINC01356 | LINC01358 | LINC01359 | LINC01360 | LINC01362 | LINC01363 | LINC01364 | LINC01366 | LINC01372 | LINC01374 | LINC01378 | LINC01387 | LINC01389 | LINC01392 | LINC01393 | LINC01394 | LINC01395 | LINC01397 | LINC01399 | LINC01405 | LINC01410 | LINC01411